Literature DB >> 15085901

Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project.

Jordi Alonso1, Montserrat Ferrer, Barbara Gandek, John E Ware, Neil K Aaronson, Paola Mosconi, Niels K Rasmussen, Monika Bullinger, Shunichi Fukuhara, Stein Kaasa, Alain Leplège.   

Abstract

CONTEXT: Few studies and no international comparisons have examined the impact of multiple chronic conditions on populations using a comprehensive health-related quality of life (HRQL) questionnaire.
OBJECTIVE: The impact of common chronic conditions on HRQL among the general populations of eight countries was assessed.
DESIGN: Cross-sectional mail and interview surveys were conducted. PARTICIPANTS AND
SETTING: Sample representatives of the adult general population of eight countries (Denmark, France, Germany, Italy, Japan, The Netherlands, Norway and the United States) were evaluated. Sample sizes ranged from 2031 to 4084. MAIN OUTCOME MEASURES: Self-reported prevalence of chronic conditions (including allergies, arthritis, congestive heart failure, chronic lung disease, hypertension, diabetes, and ischemic heart disease), sociodemographic data and the SF-36 Health Survey were obtained. The SF-36 scale and summary scores were estimated for individuals with and without selected chronic conditions and compared across countries using multivariate linear regression analyses. Adjustments were made for age, gender, marital status, education and the mode of SF-36 administration.
RESULTS: More than half (55.1%) of the pooled sample reported at least one chronic condition, and 30.2% had more than one. Hypertension, allergies and arthritis were the most frequently reported conditions. The effect of ischemic heart disease on many of the physical health scales was noteworthy, as was the impact of diabetes on general health, or arthritis on bodily pain scale scores. Arthritis, chronic lung disease and congestive heart failure were the conditions with a higher impact on SF-36 physical summary score, whereas for hypertension and allergies, HRQL impact was low (comparing with a typical person without chronic conditions, deviation scores were around -4 points for the first group and -1 for the second). Differences between chronic conditions in terms of their impact on SF-36 mental summary score were low (deviation scores ranged between -1 and -2).
CONCLUSIONS: Arthritis has the highest HRQL impact in the general population of the countries studied due to the combination of a high deviation score on physical scales and a high frequency. Impact of chronic conditions on HRQL was similar roughly across countries, despite important variation in prevalence. The use of HRQL measures such as the SF-36 should be useful to better characterize the global burden of disease.

Entities:  

Mesh:

Year:  2004        PMID: 15085901     DOI: 10.1023/b:qure.0000018472.46236.05

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  41 in total

1.  The quality of life in acne: a comparison with general medical conditions using generic questionnaires.

Authors:  E Mallon; J N Newton; A Klassen; S L Stewart-Brown; T J Ryan; A Y Finlay
Journal:  Br J Dermatol       Date:  1999-04       Impact factor: 9.302

Review 2.  Health status assessment methods for adults: past accomplishments and future challenges.

Authors:  C A McHorney
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

3.  Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

Authors:  R G Watson; T C Tham; B T Johnston; N I McDougall
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

4.  [Population reference values of the Spanish version of the Health Questionnaire SF-36].

Authors:  J Alonso; E Regidor; G Barrio; L Prieto; C Rodríguez; L de la Fuente
Journal:  Med Clin (Barc)       Date:  1998-10-10       Impact factor: 1.725

5.  The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  J E Ware; M Kosinski; B Gandek; N K Aaronson; G Apolone; P Bech; J Brazier; M Bullinger; S Kaasa; A Leplège; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

6.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

7.  Comparison of changes in physical functioning of elderly patients with new diagnoses of cancer.

Authors:  C W Given; B Given; F Azzouz; M Stommel; S Kozachik
Journal:  Med Care       Date:  2000-05       Impact factor: 2.983

8.  Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups.

Authors:  A L Komaroff; L R Fagioli; T H Doolittle; B Gandek; M A Gleit; R T Guerriero; R J Kornish; N C Ware; J E Ware; D W Bates
Journal:  Am J Med       Date:  1996-09       Impact factor: 4.965

9.  Quality of life in patients with panic disorder.

Authors:  P J Candilis; R Y McLean; M W Otto; G G Manfro; J J Worthington; S J Penava; P C Marzol; M H Pollack
Journal:  J Nerv Ment Dis       Date:  1999-07       Impact factor: 2.254

10.  Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study.

Authors:  K Midthjell; J Holmen; A Bjørndal; G Lund-Larsen
Journal:  J Epidemiol Community Health       Date:  1992-10       Impact factor: 3.710

View more
  264 in total

1.  Worsening trends and increasing disparities in health-related quality of life: evidence from two French population-based cross-sectional surveys, 1995-2003.

Authors:  Etienne Audureau; Stéphane Rican; Joël Coste
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

Review 2.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

3.  Physical activity in different domains and health-related quality of life: a population-based study.

Authors:  Danijel Jurakić; Zeljko Pedišić; Zrinka Greblo
Journal:  Qual Life Res       Date:  2010-07-15       Impact factor: 4.147

4.  Prevalence of chronic non-cancer pain in a UK prison environment.

Authors:  Michael Croft; Rachel Mayhew
Journal:  Br J Pain       Date:  2015-05

5.  Association between HTR2A T102C polymorphism and major depressive disorder: a meta-analysis in the Chinese population.

Authors:  Chun-Xia Lin; Zhe Hu; Ze-Ming Yan; Wen Li; Yu-Sen Chen; Jiang-Hao Zhao; Liang-Qing Zhang; Bin Zhao; Wang-Tao Zhong; Du Feng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  The longitudinal association between weight change and health-related quality of life: the KORA S4/F4 cohort study.

Authors:  Michael Laxy; Rolf Holle; Angela Döring; Annette Peters; Matthias Hunger
Journal:  Int J Public Health       Date:  2013-09-03       Impact factor: 3.380

7.  Factorial invariance of the WHOQOL-BREF among disease groups.

Authors:  Grace Yao; Chia-huei Wu
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

8.  Cross-geographic region differences in quality of life in women with and without vertebral fracture.

Authors:  N M van Schoor; H Yu; J Bobula; P Lips
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

9.  Construct validity of the SF-12 among American Indian and Alaska Native people using two known scoring methods.

Authors:  Sandra L Edwards; Molly McFadden; Anne P Lanier; Maureen A Murtaugh; Elizabeth D Ferucci; Diana G Redwood; Lillian Tom-Orme; Martha L Slattery
Journal:  J Health Care Poor Underserved       Date:  2012-08

10.  Associations between neighborhood characteristics and self-rated health: a cross-sectional investigation in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort.

Authors:  Kristin Tomey; Ana V Diez Roux; Philippa Clarke; Teresa Seeman
Journal:  Health Place       Date:  2013-10-12       Impact factor: 4.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.